Cite
Human iPSC-derived mesoangioblasts, like their tissue-derived counterparts, suppress T cell proliferation through IDO- and PGE-2-dependent pathways [v1; ref status: indexed, http://f1000r.es/x3]
MLA
Ou Li, et al. “Human IPSC-Derived Mesoangioblasts, like Their Tissue-Derived Counterparts, Suppress T Cell Proliferation through IDO- and PGE-2-Dependent Pathways [v1; Ref Status: Indexed, Http://F1000r.Es/X3].” F1000Research, vol. 2, Jan. 2013. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doajarticles..4be0423e208057ea4daa21421786bf55&authtype=sso&custid=ns315887.
APA
Ou Li, Karen English, Rossana Tonlorenzi, Giulio Cossu, Francesco Saverio Tedesco, & Kathryn J Wood. (2013). Human iPSC-derived mesoangioblasts, like their tissue-derived counterparts, suppress T cell proliferation through IDO- and PGE-2-dependent pathways [v1; ref status: indexed, http://f1000r.es/x3]. F1000Research, 2.
Chicago
Ou Li, Karen English, Rossana Tonlorenzi, Giulio Cossu, Francesco Saverio Tedesco, and Kathryn J Wood. 2013. “Human IPSC-Derived Mesoangioblasts, like Their Tissue-Derived Counterparts, Suppress T Cell Proliferation through IDO- and PGE-2-Dependent Pathways [v1; Ref Status: Indexed, Http://F1000r.Es/X3].” F1000Research 2 (January). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doajarticles..4be0423e208057ea4daa21421786bf55&authtype=sso&custid=ns315887.